This partnership marks a significant step in leveraging the power of AI to enhance clinical trial outcomes. Perceiv AI's AD-Px™ engine, known for its ability to forecast disease progression in ...

A new study reveals a mutation mechanism in osteosarcoma, promising advances in treatment and prognosis for this challenging ...

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 ...

The Nijmegen, Netherlands-based firm said that the algorithm is used in its Aiosyn Mitosis Breast software to aid tumor grading and provide a prognostic indicator that can be used to guide treatment ...

Atropos Health, a pioneer in translating clinical real-world data into personalized real-world evidence (RWE) and insights, and xCures, a pioneer in AI-powered healthcare data retrieval, extraction ...

The Florey Dementia Index (FDI) is valid for predicting the age of onset of mild cognitive impairment (MCI) and Alzheimer ...

For acute lymphoblastic leukemia (ALL) and central nervous system (CNS) tumors, the adverse prognostic impact of obesity was ...

“The most interesting and rewarding aspect of the work we do in the Karikari Lab is our focus on the identification of new ...

Published in Clinical Cancer Research, results of a VHIO-led study underscore the potential of the RAD51 biomarker in ...

CEL-SCI Corporation reported financial results for the fiscal year ended September 30, 2024, as well as key clinical and corporate developments. "We are very optimistic about the prospects of our ...

Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...